Practice Insights: Managing T2DM in Older Adults

Volume 1, Issue 4

Practice Insights: Managing T2DM in Older Adults

In this issue:

Avoiding hypoglycemia, recognizing cognitive dysfunction, and individualizing treatment to account for renal insufficiency, cardiovascular disease and other comorbidities — these are just some of the factors that impact treatment decision-making for older adults with type 2 diabetes.

In this issue, Dr. Amisha Wallia (Feinberg School of Medicine) and Dr. Susan Karam (Ochsner Medical Center) take us to the exam room to translate the information from their recent Newsletter Issue into real-world clinical practice.

Learning objectives:

Summarize appropriate screening related to both chronic diabetes complications as well as general health for older adults with diabetes.
Discuss medication management in older adults with multiple comorbidities, including renal insufficiency.
Describe goals of care and medication management for patients with type 2 diabetes in nursing homes, as well as at the end of life.

Authors:

Susan Karam, MD

Department of Endocrinology
Ochsner Health System
Jefferson, LA

Amisha Wallia, MD

Assistant Professor of Medicine
Northwestern Medicine
Feinberg School of Medicine
Chicago, IL

Guest Faculty Disclosures

Dr. Wallia has disclosed that she has performed contracted research as a principal investigator for Novo Nordisk and as a co-investigator for Eli Lilly and Company.

Dr. Karam has indicated that she has no financial interests or relationships with a commercial entity.

Unlabeled/Unapproved Uses

Dr. Wallia & Dr. Karam have indicated that there will be no references to the unlabeled/unapproved uses of any drugs or products.

Program Directors:

Joyce King, MD

Assistant Professor
Georgetown University School of Medicine
Director, Inpatient Medicine
Family Medicine Residency Program
Medstar Franklin Square Hospital
Baltimore, MD

Glenn Treisman, MD, PhD

Eugene Meyer III Professor of Psychiatry and Medicine
Director, AIDS Psychiatry Services
Co-Director, Chronic Pain Treatment Program
Johns Hopkins University School of Medicine
Baltimore, MD

Guest Faculty Disclosures:

Dr. Wallia has disclosed that she has performed contracted research as a principal investigator for Novo Nordisk and as a co-investigator for Eli Lilly and Company.

Dr. Karam has indicated that she has no financial interests or relationships with a commercial entity.

Unlabeled/Unapproved Uses:

Dr. Wallia & Dr. Karam have indicated that there will be no references to the unlabeled/unapproved uses of any drugs or products.

Length of activity:

0.5 hour Physicians

Launch date: August 17, 2019
Expiration date: August 16, 2021

Start Issue